🔎 Trials Near Me

Beranda › Pendarahan › California

Uji klinis Pendarahan di California

12 studi untuk Pendarahan mencari peserta di lokasi di California.

Kota di California

Teks studi resmi (Bahasa Inggris)

CAlcium and VAsopressin Following Injury Early Resuscitation (CAVALIER) Trial

  • Zuckerberg San Francisco General Hospital and Trauma Center at University of California, San Francisco, San Francisco
Menerima pesertaFase 2
Usia 18 hingga 90 · Semua jenis kelamin · Diperbarui 29 Sep 2026 · NCT05958342

Safety in Adult Participants With Atrial Fibrillation Who Are Treated With Anticoagulation

  • Valley Clinical Trials, Inc, Covina
  • North Coast Cardiology, Encinitas
  • Mission Cardiovascular Research Institute, Fremont
  • dan 7 lainnya
Menerima pesertaFase 2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 28 Sep 2026 · NCT07175428

Stroke and Systemic Embolism Prevention in Adult Participants With Atrial Fibrillation

  • Mission Cardiovascular Research Institute, Fremont
  • National Institute of California Heart and Vein Specialists, Huntington Beach
  • Profound Research LLC at San Diego Cardiovascular Associates, La Jolla
  • dan 5 lainnya
Menerima pesertaFase 3
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 28 Sep 2026 · NCT07626411

Onyx™ Liquid Embolic IDE Clinical Study

  • University of California, Irvine, Irvine
  • Stanford Medical Center, Palo Alto
Menerima peserta
Usia 22 ke atas · Semua jenis kelamin · Diperbarui 21 Sep 2026 · NCT06742801

A Study of Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia

  • USC Norris Comprehensive Cancer Center - Keck Medicine of USC, Los Angeles
  • University of California San Diego Center for Bleeding and Clotting Disorders, San Diego
Menerima pesertaFase 3
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 18 Sep 2026 · NCT06722235

A Follow-up Study of Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia

  • USC Norris Comprehensive Cancer Center - Keck Medicine of USC, Los Angeles
  • University of California San Diego Center for Bleeding and Clotting Disorders, San Diego
Menerima pesertaFase 3
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 9 Sep 2026 · NCT06948318

Oxytocin Pharmacokinetics and Pharmacodynamics

  • Stanford University, Stanford
Menerima pesertaFase 2
Usia 18 hingga 50 · Wanita · Diperbarui 21 Agu 2026 · NCT05488457

Pharmacokinetics, Pharmacodynamics, and Safety Profile of Understudied Drugs Administered to Children Per Standard of Care (POPS)

  • Lucile Packard Children's Hospital, Palo Alto
Menerima pesertaStudi observasionalSukarelawan sehat diterima
Usia 0 hingga 20 · Semua jenis kelamin · Diperbarui 21 Agu 2026 · NCT04278404

A Study to Compare the Efficacy and Safety of TachoSil and Surgicel Original as an Adjunct to Control Mild to Moderate Soft Tissue Bleeding During Surgery

  • Torrance Memorial, Torrance
Menerima pesertaFase 3
1 Month · Semua jenis kelamin · Diperbarui 30 Jun 2026 · NCT06664775

Anticoagulation for New-Onset Post-Operative Atrial Fibrillation After CABG

  • University of Southern California, Los Angeles
  • Cedars-Sinai Medical Center, Los Angeles
  • Stanford University, Stanford
Menerima pesertaFase 3
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 26 Jun 2026 · NCT04045665

Tranexamic Acid for Second Trimester Dilation and Evacuation and Bleeding Outcomes

  • University of California San Diego, San Diego
  • Planned Parenthood of the Pacific Southwest, San Diego
Menerima pesertaFase 4Sukarelawan sehat diterima
Usia 18 ke atas · Wanita · Diperbarui 15 Jun 2026 · NCT06820177

Safety and Effectiveness of Giroctocogene Fitelparvovec or Fidanacogene Elaparvovec in Patients With Hemophilia A or B Respectively

  • The Regents of the University of California||UC Davis Health, Rancho Cordova
  • UC Davis Health, Sacramento
  • UC Davis Ambulatory Care Clinic, Sacramento
  • dan 3 lainnya
Menerima pesertaFase 3
Usia 18 ke atas · Pria · Diperbarui 27 Mei 2026 · NCT05568719

Dari ClinicalTrials.gov, data diambil 2 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.